ArticleTransboundary and emerging diseases2021
The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.
Article in Transboundary and emerging diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities.Genome biology · 2026Review
- Excess mortality during COVID-19 and prediction of mortality in Bangladesh: an analysis based on death records in urban graveyards.Journal of global health · 2025Article
- A Strategic Framework of SARS-CoV-2 Genomic Surveillance in Bangladesh.Influenza and other respiratory viruses · 2024Article
- Article
- Review
- Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.Journal of global health · 2024Observational
- Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology.MethodsX · 2024Article
- Article
- SARS-CoV-2 variant survey: Comparison of RT-PCR screening with TGS and variant distribution across two divisions of Bangladesh.PloS one · 2024Article
- Monitoring SARS-CoV-2 variants in wastewater of Dhaka City, Bangladesh: approach to complement public health surveillance systems.Human genomics · 2023Article
- SARS-CoV-2 Omicron variants in Bangladesh: Pandemic to endemic.Health science reports · 2023Article
- Risk factors for COVID-19 mortality among telehealth patients in Bangladesh: A prospective cohort study.PLOS global public health · 2023Article
- Performance Evaluation of Developed Bangasure™ Multiplex rRT-PCR Assay for SARS-CoV-2 Detection in Bangladesh: A Blinded Observational Study at Two Different Sites.Diagnostics (Basel, Switzerland) · 2022Article
- Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh.Tropical medicine and infectious disease · 2022Article
- Determination of COVID-19 PCR positivity and mutation status in coronaVac vaccinated individuals in Turkey.Turkish journal of medical sciences · 2022Article
- Article
- Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection.IJID regions · 2022Article
- Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh.Journal of infection and public health · 2022Article
- COVID-19 reinfections among naturally infected and vaccinated individuals.Scientific reports · 2022Article
- Health-related quality of life and coping strategies adopted by COVID-19 survivors: A nationwide cross-sectional study in Bangladesh.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.